InfuSystem Holdings, Inc. (NYSE:INFU – Get Free Report)’s stock price rose 1.9% during trading on Thursday . The company traded as high as $7.90 and last traded at $7.90. Approximately 95,199 shares traded hands during trading, a decline of 32% from the average daily volume of 139,282 shares. The stock had previously closed at $7.75.
Analysts Set New Price Targets
Separately, Roth Mkm reiterated a “buy” rating and set a $14.00 price target (up previously from $13.00) on shares of InfuSystem in a research report on Tuesday, November 4th. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $14.50.
View Our Latest Analysis on InfuSystem
InfuSystem Trading Up 1.9%
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. Minerva Advisors LLC grew its holdings in InfuSystem by 5.2% in the 4th quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company’s stock valued at $9,676,000 after buying an additional 52,942 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of InfuSystem by 1.9% during the 3rd quarter. Vanguard Group Inc. now owns 976,177 shares of the company’s stock valued at $10,113,000 after acquiring an additional 18,539 shares during the last quarter. Punch & Associates Investment Management Inc. grew its holdings in shares of InfuSystem by 1.9% in the fourth quarter. Punch & Associates Investment Management Inc. now owns 824,750 shares of the company’s stock valued at $7,398,000 after purchasing an additional 15,000 shares during the period. Renaissance Technologies LLC grew its holdings in shares of InfuSystem by 2.0% in the fourth quarter. Renaissance Technologies LLC now owns 587,509 shares of the company’s stock valued at $5,270,000 after purchasing an additional 11,795 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in InfuSystem by 0.8% during the third quarter. Dimensional Fund Advisors LP now owns 569,238 shares of the company’s stock worth $5,898,000 after purchasing an additional 4,430 shares during the last quarter. 71.13% of the stock is owned by hedge funds and other institutional investors.
InfuSystem Company Profile
InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.
In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.
Featured Articles
- Five stocks we like better than InfuSystem
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.
